A new biomarker discovered by researchers from the University of Michigan Health Rogel Cancer Center could help identify which renal cancer patients have a higher risk of recurrence. Simpa S. Salami, M.D., M.P.H, associate professor of urology at Michigan Medicine and lead author of the study, describes his team’s findings and implications for future treatments of renal cancer.
